Methylprednisolone Induces Neuro-Protective Effects via the Inhibition of A1 Astrocyte Activation in Traumatic Spinal Cord Injury Mouse Models
Open Access
- 31 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
Traumatic spinal cord injury (TSCI) leads to pathological changes such as inflammation, edema, and neuronal apoptosis. Methylprednisolone (MP) is a glucocorticoid that has a variety of beneficial effects, including decreasing inflammation and ischemic reaction, as well as inhibiting lipid peroxidation. However, the efficacy and mechanism of MP in TSCI therapy is yet to be deciphered. In the present study, MP significantly attenuated the apoptotic effects of H2O2 in neuronal cells. Western blot analysis demonstrated that the levels of apoptotic related proteins, Bax and cleaved caspase-3, were reduced while levels of anti-apoptotic Bcl-2 were increased. In vivo TUNEL assays further demonstrated that MP effectively protected neuronal cells from apoptosis after TSCI, and was consistent with in vitro studies. Furthermore, we demonstrated that MP could decrease expression levels of IBA1, Il-1α, TNFα, and C3 and suppress A1 neurotoxic reactive astrocyte activation in TSCI mouse models. Neurological function was evaluated using the Basso Mouse Scale (BMS) and Footprint Test. Results demonstrated that the neurological function of MP-treated injured mice was significantly increased. In conclusion, our study demonstrated that MP could attenuate astrocyte cell death, decrease microglia activation, suppress A1 astrocytes activation, and promote functional recovery after acute TSCI in mouse models.Keywords
This publication has 49 references indexed in Scilit:
- Genomic Analysis of Reactive AstrogliosisJournal of Neuroscience, 2012
- Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expressionAnnals Of The Rheumatic Diseases, 2011
- Antioxidant Therapies for Acute Spinal Cord InjuryNeurotherapeutics, 2011
- Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytesGlia, 2008
- A new in vitro model of the glial scar inhibits axon growthGlia, 2008
- Impaired olfaction in mice lacking aquaporin‐4 water channelsThe FASEB Journal, 2008
- Basso Mouse Scale for Locomotion Detects Differences in Recovery after Spinal Cord Injury in Five Common Mouse StrainsJournal of Neurotrauma, 2006
- Fluoro-Jade B Stains Quiescent and Reactive Astrocytes in the Rodent Spinal CordJournal of Neurotrauma, 2003
- Presence or absence of TrKA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projectionsJournal of Comparative Neurology, 1995
- Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissueExperimental Neurology, 1981